98%
921
2 minutes
20
Background: This systematic review and meta-analysis aimed to evaluate the impact of perioperative immunonutrition on postoperative outcomes in patients undergoing pancreaticoduodenectomy (PD).
Methods: Conducted a comprehensive search in PubMed, Embase, Cochrane Library, Medline, and Web of Science databases to identify all randomized controlled trials (RCTs) on the topic of immunonutrition and PD. Subsequently screened literature, extracted data, and assessed the risk of bias in the included studies, and finally conducted a meta-analysis using RevMan 5.3 software.
Results: The analysis included a total of 10 RCTs with 574 patients, among whom 288 were in the immunonutrition group and 283 in the control group. The meta-analysis revealed a significantly lower incidence of postoperative infection-related complications (OR = 0.45; 95% CI: 0.27-0.74; P = 0.002) and severe postoperative complications (OR = 0.61; 95% CI: 0.38-0.98; P = 0.04) in the immunonutrition group compared to the control group. Additionally, patients in the immunonutrition group had a significantly shorter length of hospital stay (MD= -1.87; 95%CI -3.29 - -0.44; P = 0.01). However, the analysis revealed no statistically significant difference in the overall complication rate between the two groups (P = 0.67). Furthermore, the incidence of specific complications and perioperative mortality rates also did not demonstrate any statistically significant differences (all P > 0.05).
Conclusions: Perioperative immunonutrition in PD patients can reduce postoperative infection-related complications, but more high-quality RCTs are needed for further validation.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11569618 | PMC |
http://dx.doi.org/10.1186/s12876-024-03510-6 | DOI Listing |
Nutrients
July 2025
Department of Medicine, Academy of Applied Medical and Social Sciences-AMiSNS: Akademia Medycznych i Spolecznych Nauk Stosowanych, 52-300 Elbląg, Poland.
Introduction: Gastrointestinal (GI) cancers are associated with high morbidity and mortality. Surgical resection, the primary treatment, often induces immunosuppression and increases the risk of postoperative complications. Perioperative immunonutrition (IMN), comprising formulations enriched with omega-3 fatty acids, arginine, nucleotides, and antioxidants, has emerged as a potential strategy to improve surgical outcomes by reducing complications, enhancing immune function, and promoting recovery.
View Article and Find Full Text PDFCir Cir
July 2025
Department of General Surgery, Bursa Yuksek Ihtisas Research and Training Hospital, Bursa. Turkey.
Objective: Our study aims to explore the predictive value of the hemoglobin, albumin, lymphocyte, and platelet (HALP) score, calculated from routine blood tests measuring HALP levels, for perioperative morbidity in rectal cancer surgery patients.
Method: We conducted a retrospective study focusing on patients who underwent elective rectal cancer surgery from January 2017 to September 2023. The study analyzed demographic, clinical, and laboratory data, including the HALP score, to assess its correlation with perioperative morbidity using logistic and linear regression analyses.
World J Gastrointest Surg
June 2025
Department of Inflammatory Bowel Disease Unit, "Metropolitan General" Hospital, Holargos 15562, Attica, Greece.
Continuously increasing reports in the international medical literature, along with current guidelines from international societies, support the view that perioperative enteral nutrition (EN) and immunonutrition offer significant benefits to patients with benign and/or malignant digestive disorders, including reduction of postoperative infections and hospital stay. A vital component of the rehabilitation of patients after major gastrointestinal surgery is a comprehensive nutritional rehabilitation program. It has been shown that implementing an integrated nutritional support program significantly improves patients' immune responses, accelerates wound healing processes, reduces pain and accompanying anxiety, and decreases hospital length of stay.
View Article and Find Full Text PDFCancers (Basel)
May 2025
The Guidelines Committee, Japanese Society of Oral and Maxillofacial Surgeons, Minato-ku, Tokyo 108-0014, Japan.
Background: This systematic review aimed to evaluate the efficacy of immunoenhancing nutritional therapy compared to conventional nutritional care in reducing perioperative complications in adult patients undergoing surgery for oral cancer. Given the unclear role of immunonutrition in this specific surgical setting, we synthesized available randomized controlled trials to assess outcomes such as surgical site infections, wound healing complications, hospital stay, and adverse events.
Methods: Patients who underwent planned oral cancer surgery were included.
Maturitas
August 2025
First Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, "Alexandra" General Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Obesity represents a global health crisis, affecting over 650 million adults worldwide and markedly influencing surgical outcomes, particularly in the context of gynecologic oncology. It serves as a considerable risk factor for perioperative complications, impacting metabolic, respiratory, immune, and cardiovascular functions. Patients with obesity undergoing surgical procedures in gynecologic oncology exhibit higher incidences of wound infections, thromboembolic events, respiratory failure, and extended hospital stays.
View Article and Find Full Text PDF